Page last updated: 2024-11-06

triethylenemelamine and Anemia, Hypoplastic

triethylenemelamine has been researched along with Anemia, Hypoplastic in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BRIDGES, JB1
BRIDGES, JM1
EDELSTYN, GJ1
LYONS, AR1
BRODY, JI1
BEIZER, LH1

Other Studies

2 other studies available for triethylenemelamine and Anemia, Hypoplastic

ArticleYear
FEOTAL LIVER SUSPENSIONS IN THE TREATMENT OF MARROW APLASIA.
    British journal of cancer, 1965, Volume: 19

    Topics: Anemia; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Fetus; Hemoglobi

1965
ALTERATION OF BLOOD GROUP ANTIGENS IN LEUKEMIC LYMPHOCYTES.
    The Journal of clinical investigation, 1965, Volume: 44

    Topics: ABO Blood-Group System; Anemia; Anemia, Aplastic; Antigens; Blood Group Antigens; Child; Chlorambuci

1965